Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study.

Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study.

Item
http://www.wikidata.org/entity/Q30463973
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other CancersNocturia: The circadian voiding disorderDrug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sampleExperience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasiaMass media release of medical research results: an analysis of antihypertensive drug prescribing in the aftermath of the calcium channel blocker scare of March 1995Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)Assessment of alpha1-adrenoceptor antagonists in benign prostatic hyperplasia based on the receptor occupancy theory.Doxazosin in the treatment of benign prostatic hypertrophy: an update.A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasiaSubtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine.Therapeutic options in the treatment of benign prostatic hyperplasia.Non-Hormonal treatment of BPH/BOOThe effect of alpha-blocker therapy on erectile functions in patients with lower urinary tract symptoms due to benign prostate hyperplasia.Single dose methodology to assess the influence of an alpha1-adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia.The use of primary and secondary doxazosin XL (8 mg) in the treatment of benign prostate hyperplasia: Is there a new approach in the event of alpha-blocker failure?Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.
P2860

Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study.

Item
http://www.wikidata.org/entity/Q30463973
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Doxazosin for the treatment of ...... se-response multicenter study.
@ast
Doxazosin for the treatment of ...... se-response multicenter study.
@en
type
label
Doxazosin for the treatment of ...... se-response multicenter study.
@ast
Doxazosin for the treatment of ...... se-response multicenter study.
@en
prefLabel
Doxazosin for the treatment of ...... se-response multicenter study.
@ast
Doxazosin for the treatment of ...... se-response multicenter study.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Doxazosin for the treatment of ...... se-response multicenter study.
@en
P2093
P304
P31
P356
10.1097/00005392-199507000-00039
P407
P433
P478
P577
P698
P921